Compare $LTRN vs $PHIO | Chartloom

Compare

$LTRN vs $PHIO

Lantern Pharma Inc · Phio Pharmaceuticals Corp

LTRN

Lantern Pharma Inc

PHIO

Phio Pharmaceuticals Corp

Compare $LTRN vs $PHIO

Comparing Lantern Pharma Inc and Phio Pharmaceuticals Corp

LTRNLantern Pharma Inc

PHIOPhio Pharmaceuticals Corp

LTRNLantern Pharma Inc

Market cap

$10M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-73.9%

52W performance

-82.3%

FCF yield

-135.8%

PHIOPhio Pharmaceuticals Corp

Market cap

$11M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-10.2%

52W performance

-59.6%

FCF yield

-107.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

LTRN

PHIO

Detailed metrics comparison

LTRN

Lantern Pharma Inc

PHIO

Phio Pharmaceuticals Corp

Market Cap

LTRN$10M

PHIO$11M

Enterprise Value

LTRN$4M

PHIO$-2M

Price

LTRN$0.81

PHIO$0.98

P/E Ratio

LTRNN/A

PHION/A

P/S Ratio

LTRN0.00x

PHIO81.74x

EV/Sales

LTRN0.00x

PHIO-11.08x

EV/EBITDA

LTRN0.00x

PHIO0.00x

P/B Ratio

LTRN3.19x

PHIO0.91x

P/FCF Ratio

LTRNN/A

PHION/A

EV/FCF

LTRN-0.26x

PHIO0.13x

PEG Ratio

LTRNN/A

PHION/A

Forward P/E (NTM)

LTRNN/A

PHION/A

Forward P/S (NTM)

LTRNN/A

PHION/A

Revenue (TTM)

LTRN$0

PHIO$0

Revenue Growth (YoY)

LTRNN/A

PHION/A

Forward Rev Growth

LTRN0.0%

PHIO0.0%

Gross Margin (TTM)

LTRN0.0%

PHIO0.0%

Operating Margin (TTM)

LTRN0.0%

PHIO0.0%

EBITDA Margin (TTM)

LTRN0.0%

PHIO0.0%

Net Margin (TTM)

LTRN0.0%

PHIO0.0%

FCF Margin (TTM)

LTRNN/A

PHION/A

Net Income (TTM)

LTRN$-19M

PHIO$-13M

FCF (TTM)

LTRN$-14M

PHIO$-12M

EPS (TTM)

LTRN-$1.50

PHIO-$1.11

ROE (TTM)

LTRN-19835.0%

PHIO-8741.0%

ROA (TTM)

LTRN-18428.0%

PHIO-7976.0%

ROIC (TTM)

LTRN-19835.0%

PHIO-8741.0%

Cash

LTRN$7M

PHIO$13M

Debt

LTRN$0

PHIO$0

Net Cash/Debt

LTRN$7M

PHIO$13M

Current Ratio (TTM)

LTRN1.96x

PHIO8.39x

Quick Ratio (TTM)

LTRN1.70x

PHIO7.62x

Debt/Equity (TTM)

LTRN0.00x

PHIO0.00x

Debt/Assets (TTM)

LTRN0.0%

PHIO0.0%

Interest Coverage (TTM)

LTRNN/A

PHION/A

Net Debt/EBITDA (TTM)

LTRN0.00x

PHIO0.00x

Beta

LTRN2.42

PHIO0.90

52W Performance

LTRN-82.3%

PHIO-59.6%

YTD Performance

LTRN-73.9%

PHIO-10.2%

% from 52W High

LTRN-82.7%

PHIO-76.6%

% from 52W Low

LTRN6.9%

PHIO20.8%

Asset Turnover (TTM)

LTRN0.00x

PHIO0.02x

FCF Yield (TTM)

LTRN-135.8%

PHIO-107.3%

Earnings Yield (TTM)

LTRN-179.9%

PHIO-113.5%

Dividend Yield (TTM)

LTRNN/A

PHION/A

Rule of 40

LTRN0.0

PHIO0.0

EV/GP/RG

LTRNN/A

PHION/A

Ticker research

View LTRN research View PHIO research

Metric	LTRN Lantern Pharma Inc	PHIO Phio Pharmaceuticals Corp
Market & Valuation
Market Cap	$10M	$11M
Enterprise Value	$4M	$-2M
Price	$0.81	$0.98
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	81.74x
EV/Sales	0.00x	-11.08x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.19x	0.91x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.26x	0.13x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-19M	$-13M
FCF (TTM)	$-14M	$-12M
EPS (TTM)	-$1.50	-$1.11
ROE (TTM)	-19835.0%	-8741.0%
ROA (TTM)	-18428.0%	-7976.0%
ROIC (TTM)	-19835.0%	-8741.0%
Financial Health
Cash	$7M	$13M
Debt	$0	$0
Net Cash/Debt	$7M	$13M
Current Ratio (TTM)	1.96x	8.39x
Quick Ratio (TTM)	1.70x	7.62x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.42	0.90
52W Performance	-82.3%	-59.6%
YTD Performance	-73.9%	-10.2%
% from 52W High	-82.7%	-76.6%
% from 52W Low	6.9%	20.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.02x
FCF Yield (TTM)	-135.8%	-107.3%
Earnings Yield (TTM)	-179.9%	-113.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View LTRN research	View PHIO research

Valuation

P/S Ratio

LTRN

0.00x

PHIO

81.74x

EV/FCF

LTRN

-0.26x

PHIO

0.13x

Growth & revenue

Forward Revenue Growth

LTRN

0.0%

PHIO

0.0%

Profitability & performance

Gross Margin

LTRN

0.0%

PHIO

0.0%

ROE

PHIO

-8741.0%

LTRN

-19835.0%

FCF Yield %

PHIO

-107.3%

LTRN

-135.8%

52-Week Performance

PHIO

-59.6%

LTRN

-82.3%

Detailed metrics comparison

LTRN

Lantern Pharma Inc

PHIO

Phio Pharmaceuticals Corp

Market Cap

LTRN$10M

PHIO$11M

Enterprise Value

LTRN$4M

PHIO$-2M

Price

LTRN$0.81

PHIO$0.98

P/E Ratio

LTRNN/A

PHION/A

P/S Ratio

LTRN0.00x

PHIO81.74x

EV/Sales

LTRN0.00x

PHIO-11.08x

EV/EBITDA

LTRN0.00x

PHIO0.00x

P/B Ratio

LTRN3.19x

PHIO0.91x

P/FCF Ratio

LTRNN/A

PHION/A

EV/FCF

LTRN-0.26x

PHIO0.13x

PEG Ratio

LTRNN/A

PHION/A

Forward P/E (NTM)

LTRNN/A

PHION/A

Forward P/S (NTM)

LTRNN/A

PHION/A

Revenue (TTM)

LTRN$0

PHIO$0

Revenue Growth (YoY)

LTRNN/A

PHION/A

Forward Rev Growth

LTRN0.0%

PHIO0.0%

Gross Margin (TTM)

LTRN0.0%

PHIO0.0%

Operating Margin (TTM)

LTRN0.0%

PHIO0.0%

EBITDA Margin (TTM)

LTRN0.0%

PHIO0.0%

Net Margin (TTM)

LTRN0.0%

PHIO0.0%

FCF Margin (TTM)

LTRNN/A

PHION/A

Net Income (TTM)

LTRN$-19M

PHIO$-13M

FCF (TTM)

LTRN$-14M

PHIO$-12M

EPS (TTM)

LTRN-$1.50

PHIO-$1.11

ROE (TTM)

LTRN-19835.0%

PHIO-8741.0%

ROA (TTM)

LTRN-18428.0%

PHIO-7976.0%

ROIC (TTM)

LTRN-19835.0%

PHIO-8741.0%

Cash

LTRN$7M

PHIO$13M

Debt

LTRN$0

PHIO$0

Net Cash/Debt

LTRN$7M

PHIO$13M

Current Ratio (TTM)

LTRN1.96x

PHIO8.39x

Quick Ratio (TTM)

LTRN1.70x

PHIO7.62x

Debt/Equity (TTM)

LTRN0.00x

PHIO0.00x

Debt/Assets (TTM)

LTRN0.0%

PHIO0.0%

Interest Coverage (TTM)

LTRNN/A

PHION/A

Net Debt/EBITDA (TTM)

LTRN0.00x

PHIO0.00x

Beta

LTRN2.42

PHIO0.90

52W Performance

LTRN-82.3%

PHIO-59.6%

YTD Performance

LTRN-73.9%

PHIO-10.2%

% from 52W High

LTRN-82.7%

PHIO-76.6%

% from 52W Low

LTRN6.9%

PHIO20.8%

Asset Turnover (TTM)

LTRN0.00x

PHIO0.02x

FCF Yield (TTM)

LTRN-135.8%

PHIO-107.3%

Earnings Yield (TTM)

LTRN-179.9%

PHIO-113.5%

Dividend Yield (TTM)

LTRNN/A

PHION/A

Rule of 40

LTRN0.0

PHIO0.0

EV/GP/RG

LTRNN/A

PHION/A

Ticker research

View LTRN research View PHIO research

Metric	LTRN Lantern Pharma Inc	PHIO Phio Pharmaceuticals Corp
Market & Valuation
Market Cap	$10M	$11M
Enterprise Value	$4M	$-2M
Price	$0.81	$0.98
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	81.74x
EV/Sales	0.00x	-11.08x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.19x	0.91x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.26x	0.13x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-19M	$-13M
FCF (TTM)	$-14M	$-12M
EPS (TTM)	-$1.50	-$1.11
ROE (TTM)	-19835.0%	-8741.0%
ROA (TTM)	-18428.0%	-7976.0%
ROIC (TTM)	-19835.0%	-8741.0%
Financial Health
Cash	$7M	$13M
Debt	$0	$0
Net Cash/Debt	$7M	$13M
Current Ratio (TTM)	1.96x	8.39x
Quick Ratio (TTM)	1.70x	7.62x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.42	0.90
52W Performance	-82.3%	-59.6%
YTD Performance	-73.9%	-10.2%
% from 52W High	-82.7%	-76.6%
% from 52W Low	6.9%	20.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.02x
FCF Yield (TTM)	-135.8%	-107.3%
Earnings Yield (TTM)	-179.9%	-113.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View LTRN research	View PHIO research